Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Teva Pharmaceutical Industries ADR
(NY:
TEVA
)
17.95
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Teva Pharmaceutical Industries ADR
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
24
25
Next >
Busy Week Ahead As Volatility Gauges Flash Red
May 08, 2023
With CPI data being released on Wednesday and the Biden administration starting talks with Congress on Tuesday, it looks like this could be a big week for volatility.
Via
Talk Markets
U.S. Mental Health Access Program Expands Medicine Donation to Seven New States
May 03, 2023
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
FDA Approves Teva/MedinCell's Antipsychotic Injection For Adult Schizophrenia Patients
May 01, 2023
Via
Benzinga
Teva and MedinCell Announce FDA Approval of UZEDY™ (risperidone) Extended-Release Injectable Suspension, a Long-Acting Subcutaneous Atypical Antipsychotic Injection, for the Treatment of Schizophrenia in Adults
April 28, 2023
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Teva to Launch New Growth Strategy at Investor Day
April 27, 2023
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
April 19, 2023
Via
Benzinga
Merck Nabs Prometheus Bio For $10.8 Billion As Keytruda Patent Expirations Loom
April 17, 2023
Merck is branching into immune-mediated diseases with this takeover.
Via
Investor's Business Daily
1 "Safe" Stock to Avoid and 1 to Consider Buying in April
April 15, 2023
There's more to the concept of safety than having a business model that looks safe.
Via
The Motley Fool
Teva to Host Conference Call to Discuss First Quarter 2023 Financial Results at 8 a.m. ET on May 10, 2023
April 14, 2023
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Why Teva Pharmaceutical Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Friday's Mid-Day Session
April 14, 2023
Gainers SAI.TECH Global Corporation (NASDAQ: SAI) jumped 269% to $5.61 after gaining around 25% on Thursday.
Via
Benzinga
Boeing, Spirit AeroSystems And Other Big Stocks Moving Lower In Friday's Pre-Market Session
April 14, 2023
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Complete Response Letter Received for AVT02 Biologics License Application
April 13, 2023
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Trillions In Biotech Stock Gains Trace Back To This Financier
April 13, 2023
Frank did not grow up as son of a Wall Street banker. He began as the consummate outsider.
Via
Investor's Business Daily
Teva to Present New Data on Once-Daily AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets at the 2023 American Academy of Neurology Annual Meeting
April 11, 2023
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Emergent BioSolutions Soars: Analyst Upgrades Stock With Near 100% Upside After FDA's Positive Move
April 10, 2023
Via
Benzinga
7 A-Rated Stocks to Buy for April 2023
April 07, 2023
Now that the first quarter's in the bank, here are seven A-rated stocks to buy for April to keep your portfolio in top-notch shape.
Via
InvestorPlace
The Byzantine Adderall Shortage Puts Teva And Others In The Hot Seat
April 05, 2023
Millions of people are scrambling to get their ADHD medication. Here's why.
Via
Investor's Business Daily
Stage Set For Generics As Biden Admin Asks Supreme Court To Hear Skinny Labels Case Between GSK, Teva
March 31, 2023
Via
Benzinga
Is Big Pharma Coming For Your Cannabis Business?
March 27, 2023
Cannabis stocks have struggled in the market in recent years as the industry push to gain ground on the regulatory front hasn't progressed as quickly as investors had hoped. Yet beverage companies...
Via
Benzinga
Teva’s Digital Health Collaboration with Rimidi Expands to Include Respiratory Monitoring Program Integration with a Large U.S. Health System
March 27, 2023
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
7 Strong Buy Stocks Under $10 to Snap Up Now
March 23, 2023
Markets are missing out on these seven strong buy stocks under $10, which trade at too good a value score for savvy investors to ignore.
Via
InvestorPlace
3 No-Brainer Stocks to Buy With $10 Right Now
March 22, 2023
You don't need a large pile of money to begin building wealth on Wall Street.
Via
The Motley Fool
Catalyst Pharma The No. 1 Biotech, Just Crushed 2023 Guidance Estimates
March 15, 2023
The guidance includes Catalyst's newest, and second, product.
Via
Investor's Business Daily
Teva Announces Early Tender Results of its Debt Tender Offer, Increases to Tender Caps and Election of Early Settlement
March 13, 2023
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
7 Core Stocks to Build a Solid Portfolio Around
March 13, 2023
You’ll enjoy your investing journey more if you know that you can rely on your core of stocks to buy to provide a solid foundation.
Via
InvestorPlace
Teva and Natco Announce Launch of additional strengths for the Generic Version of Revlimid® (lenalidomide capsules), in the U.S.
March 09, 2023
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
BRTX’s ThermoStem®: A New Weapon In The Fight Against Metabolic Syndrome
March 09, 2023
By Julian Richard, Benzinga
Via
TheNewswire.com
BRTX’s ThermoStem®: A New Weapon In The Fight Against Metabolic Syndrome
March 09, 2023
BRTX’s ThermoStem®: A New Weapon In The Fight Against Metabolic Syndrome
Via
News Direct
BRTX's ThermoStem®: A New Weapon In The Fight Against Metabolic Syndrome
March 08, 2023
Metabolism is the chemical process whereby the body produces energy from food. By breaking down carbohydrates and fats into sugars, the cells access fuel that can be used or stored via the liver or...
Via
Benzinga
Teva to Present at the Barclays Global Healthcare Conference
March 07, 2023
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
24
25
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.